Inicio › TXCELL › Noticias › Executive interview - TxCell TXCELL FichaNoticiasAnálisisGeneralMuro Apertura: - Cambio neto: - Volumen: - Mínimo: - Máximo: - Distancia Mín/Máx: - Tipo: Acciones Ticker: TXCL ISIN: FR0010127662 Ficha Noticias Análisis General Muro Executive interview - TxCell 146 0 TxCell offers a rare investment opportunity as it is the only company applying CAR-T technology to regulatory T-cells (Tregs) for autoimmune and inflammatory ... Edison